As of January 2026 Prelude Therapeutics has a market cap of $0.18 Billion USD. This makes Prelude Therapeutics the world's 8621th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 1st, 2026 the market cap of Prelude Therapeutics was reported to be: